ABSTRACT We have found that the peripheral blood of normal humans contains a significant number of committed erythroid stem cells of high proliferative capacity. These erythroid stem cells closely resemble the murine erythroid burst-forming unit (BFU-E) with respect to proliferative capacity, colony morphology, and erythropoietin requirement.
tested. The ability to assay significant numbers of erythroid precursor cells of high proliferative capacity from normal peripheral blood should facilitate the study of both normal erythropoiesis and of disease states affecting erythropoiesis in which marrow samples are not available on a routine basis. The analysis of erythropoiesis in the mouse has been advanced significantly by the development and application of techniques for cloning committed erythroid precursor cells in vitro (1) (2) (3) (4) (5) . Recently, these techniques have been extended for use with human erythroid precursor cells (6, 7) . In the mouse, Heath et al. clearly demonstrate the existence of two distinct cell populations in the marrow, BFU-E (burst-forming unit that responds to erythropoietin) and CFU-E (colony-forming unit that responds to erythropoietin) (8) . These populations can be distinguished by a number of characteristics, including cell volume, responsiveness to erythropoietin, and proliferative capacity. Axelrad et al. (4, 8) have proposed that BFU-E, a cell which differentiates in response to a high dose of erythropoietin and has a relatively high proliferative capacity (colony size 64-1000 cells), is the precursor of CFU-E, a cell of lower proliferative capacity (colony size 8-64 cells), although direct experimental evidence to support this view is not currently available.
Previous analysis of human erythroid precursor cells has focused primarily on cells obtained from bone marrow aspirates. The extent of proliferation of cells obtained from human bone marrow has generally been less than that observed for mouse BFU-E-derived colonies. In the only previous report on erythroid precursor cells in human peripheral blood a very limited proliferative capacity was also observed (9) . In the present study we demonstrate the presence in human peripheral blood of a cell with a proliferative capacity equivalent to that of murine BFU-E. The morphological appearance of the erythroid colonies derived from human peripheral blood cells bears a striking resemblance to that of mouse BFU-E colonies. The demonstration of significant numbers or proliferative capacity of early erythroid precursors in human peripheral blood could have important implications both for the understanding of normal erythropoiesis and for the analysis of disease states affecting erythrocyte formation.
MATERIALS AND METHODS Samples (50 ml) of normal human peripheral blood were drawn and mixed with either 0.4% sodium citrate or preservative-free acid-citrate-dextrose. Mononuclear cells were separated from erythrocytes using a modification of the Ficoll-Hypaque density centrifugation technique (10) . Briefly, 25 ml of undiluted blood was layered onto 25 ml of Ficoll-Hypaque (Pharmacia Ltd., Piscataway, N.J.) and centrifuged at 960 X g for 20 min at 20°. The mononuclear cell layer was collected, washed once in ice-cold alpha minimum essential medium containing 0.4% sodium citrate, and resuspended in alpha minimum essential medium without citrate at the desired cell concentration. The mononuclear cell fraction contained a high proportion of both monocytes and lymphocytes and was routinely observed to contain more than 50% nucleated cells after a single Ficoll-Hypaque density centrifugation. Nucleated cell concentration was determined by hemocytometer count of cells suspended in 10% acetic acid.
Further operations were carried out at 4°. Mononuclear cells were plated in a final volume of 0.1 ml in plastic microtiter wells (MRC no. 96 Linbro Chemical Co., New Haven, Conn.) using the plasma culture technique (2, 8) . A modification of the technique that yielded substantially higher plating efficiencies involved replacing beef embryo extract with a final concentration of 1.0 units/ml of semi-purified bovine thrombin (Grade 1, Sigma Chemical Co., St. Louis, Mo.). Either human urinary erythropoietin (lot H-11-TaLSL, U.S. National Institutes of Health) or erythropoietin from anemic sheep plasma (Step III, Connaught Laboratories, Willowdale, Ontario, Canada) was added at the desired concentrations, 0.5-4 units/ml, at zero time. Cultures were incubated in an atmosphere of high humidity and 95% air/5% CO2 at 370 for various periods. Squash preparations were prepared as previously described (2) . Cytocentrifuge preparations were obtained by releasing cells from clots by treatment of 0.1 ml of clot with 0.3 ml of Pronase at 1 mg/ml (Grade B, Calbiochem, La Jolla, Calif.) dissolved in phosphate-buffered physiologic salt solution for 2 min and pelleting the released cells onto a slide at 500 rpm for 5 min in a Shandon cytocentrifuge. 59Fe radioautography was performed essentially as described (1) . Cultures were labeled from 
RESULTS
Initial experiments involved plating the nucleated cell fraction isolated from peripheral blood by Ficoll-Hypaque density centrifugation in the plasma culture system. After 10-14 days of incubation at 370 in the presence of erythropoietin, macroscopic benzidine-positive colonies with characteristics similar to those of murine BFU-E-derived colonies were observed. The human erythroid colonies contained more than 100 cells and were composed of discrete subcolonies.
A low-power view (Fig. 1A) shows the appearance of these colonies in squash preparations permitting colony counts at a magnification of about loX. Fig. 1B shows the absence of colonies in the absence of erythropoietin. Fig. IC illustrates the morphology of BFU-E-derived colonies in the plasma clot at a magnification of 32X. The typical grouping of microscopic subcolonies within a macroscopic colony was thus visible both in culture (Fig. 1C ) and in squash preparations (Fig. 1D) . After 14 days of incubation cells were harvested from plasma culture and cytocentrifuge preparations were made. More than 20% of the cells observed were benzidine-positive and had the characteristic morphology of erythroid cells ( Fig. IF and G) .
In a typical colony almost every cell stained intensely with benzidine-peroxide reagent. To further substantiate the presence of hemoglobin in the cells of each colony, 59Fe incorporation followed by autoradiography was performed. A strong autoradiographic response was observed only in the areas of the emulsion directly over a macroscopic colony. A typical result is shown at a magnification of 200X in Fig. IE . Development of erythroid colonies was also accompanied by synthesis of globin and globin mRNA (B. Forget, B. J. Clarke, and D. Housman, unpublished observation).
In Table 1 colony morphology has been quantitated as a function of time and dose of erythropoietin. Few colonies greater than eight cells are observed prior to 7 days of incubation. In a range of erythropoietin dosage of [1] [2] [3] [4] units/ml the number of colonies and the time course of increase of benzidine-positive colonies were similar up to 13 days, when a plateau in colony number and proportion of large benzidinepositive colonies began. It should be noted that significant numbers of erythroid colonies appeared only in the presence of added erythropoietin. Between 16 and 18 days of incubation cultures began to deteriorate and extensive lysis of cells in erythroid colonies developed.
Very few mature granulocytic colonies developed in these cultures either in the presence or in the absence of erythropoietin. In all cultures containing erythropoietin, large numbers of benzidine-negative colonies were in evidence from day 7-9 (Table 1) . However, with increasing incubation time, greater than 80% of the colonies became strongly benzidine-positive for heme and contained cells whose nuclear morphology was uniformly erythroid (Table 1, Fig. 1 ). Even with the highest concentration of erythropoietin employed (4 units/ml) and the longest incubation period (18 days), a residual 10-20% of the colonies remained benzidine-negative (Table 1) . On a strictly morphological basis it was unclear whether these were immature granulocytic colonies or committed erythroid precursor cells which had not differentiated to the point of hemoglobin synthesis.
In Fig. 2 human and sheep erythropoietin are compared with respect to their ability to promote formation of macroscopic erythroid colonies. There was no significant difference in dose response between human and sheep erythropoietin at any concentration and a plateau of about 30 BFU-E-derived colonies per 5 X 105 nucleated cells plated was observed using erythropoietin at 1-4 units/ml. In some experiments a trend towards larger colony size at a higher erythropoietin dose was noted. For this reason a dose of 4 units/ml was chosen for subsequent experiments.
An analysis of colony size versus time of incubation is shown in Fig. 3 . Average colony size increased from about 100 cells at day 7 to 350 at day 11-13. A moderate increase in colony size was observed between day 11 and day 16. The mean number of subcolonies per macroscopic colony also increased from a value of Sat day 7 to maximum of 6 to 7 at day 13 
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Proc. Natl. Acad. Sci. USA 74(1977) 1107 Data are based on three replicate cultures seeded at 3 X 105 nucleated cells per culture. Sufficient cells to perform the experiment were obtained by drawing 50 ml of blood from a single individual. Sheep erythropoietin was used in all experimental groups. A minimum colony size for benzidine-negative colonies was considered to be eight cells.
tential diagnostic value it must have a linear response with respect to cell input and a relatively narrow range of values when a series of normal subjects are assayed. Results suggesting that the assay meets these requirements are presented in Fig. 4 and Table 2 . Fig. 4 BFU-E per ml of peripheral blood.
DISCUSSION
The dependence on a high concentration of erythropoietin, distinctive morphology, and large size of the erythroid colonies generated by cells present in human peripheral blood constitute strong evidence that these cells are analogous to murine BFU-E (3, 4, 8) . The morphology peculiar to BFU-E-derived colonies is intrinsically interesting. Axelrad et al. (4) have hypothesized that the typical clustering of subcolonies observed in murine BFU-E-derived colonies is due to a period of motility during the differentiation of BFU-E to CFU-E. Because peripheral blood contains far fewer cell types than bone marrow, direct observation of human BFU-E cultures by time lapse cinematography may facilitate the characterization of this stage in the differentiation of BFU-E to the erythrocyte. As in the murine system, the in vvo role of the putative motile phase remains to be established.
Another important problem will be to establish cell surface characteristics of human BFU-E in order to obtain highly purified BFU-E populations. Immunological techniques for separating lymphocyte subsets have recently been employed to demonstrate that granulocytic precursor cells (CFU-C) found in human peripheral blood are localized in the null lymphocyte fraction (11) . Results obtained by us in collaboration with C. Richman (unpublished) suggest that human peripheral blood BFU-E are also found primarily in the null lymphocyte subset.
Our observations raise a significant question about the role of peripheral blood BFU-E in normal erythropoiesis. Do these cells simply represent an overflow from the marrow into the peripheral blood or could they be an important vehicle for redistributing erythropoiesis from one site in the marrow to another? One striking aspect of our results is that the erythroid precursor cells from peripheral blood appear to exhibit a higher proliferative capacity than has yet been reported for cells from human marrow (6, 7) . Preliminary experiments in our laboratory suggest that bone marrow cells plated under identical experimental conditions give rise to smaller erythroid colonies than peripheral blood cells. These observations raise the question of suppressor cells in the marrow population. Heath et al. iments between marrow and peripheral blood cells should help to resolve these issues in the human system.
The presence of an erythroid precursor cell of high proliferative capacity in human peripheral blood is of potential significance to a number of approaches to human erythropoiesis. The ability to cultivate a relatively synchronous cohort of normal erythroid precursor cells in vitro should facilitate biochemical analysis of early events in human erythropoiesis. For example, the routine availability of early erythroid precursor cells should facilitate study of the switch from adult to fetal hemoglobin synthesis in vitro (12) . We have found that globin synthesis in the thalassemia syndromes can now be studied using peripheral blood precursor cells rather than cells from marrow aspirates. Globin chain production by peripheral blood BFU-E-derived erythroid colonies from a number of thalassemia patients clearly demonstrates imbalance of globin chain synthesis similar in magnitude to that observed in reticulocyte lysates from the same individuals (B. Forget, B. J. Clarke, and D. Housman, unpublished observations). Our observations also appear to be relevant to clinical situations involving other disorders of erythropoiesis. Recent results from our laboratory have indicated that three patients with Blackfan-Diamond anemia had no detectableBFU-E in the peripheral blood before ameliorating steroid treatment began (13) . Once in clinical remission the same patients had detectable but abnormally low numbers of BFU-E in their blood (13) . It 
